Decreased expression of MT1E is a potential biomarker of prostate cancer progression

Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR) of the disease. Microarray-based gene expression profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Demidenko, Rita, Daniunaite, Kristina, Bakavicius, Arnas, Sabaliauskaite, Rasa, Skeberdyte, Aiste, Petroska, Donatas, Laurinavicius, Arvydas, Jankevicius, Feliksas, Lazutka, Juozas R., Jarmalaite, Sonata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617458/
https://www.ncbi.nlm.nih.gov/pubmed/28977898
http://dx.doi.org/10.18632/oncotarget.18683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617458/
https://www.ncbi.nlm.nih.gov/pubmed/28977898
http://dx.doi.org/10.18632/oncotarget.18683

Ejemplares similares